Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | SCN1A | P35498 | 2/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | LOX | P28300 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.46 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117507 | 0.82 | CYP3A4 (0.58) | KDM4ECYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL27403973 | 0.79 | CA1 (0.58) | CA2CA1CA9SCN1ASCN2A | |
| SCHEMBL27207049 | 0.79 | CA1 (0.46) | CA2CA1CA9SCN1ASCN2A | |
| SCHEMBL1195872 | 0.78 | TTR (0.42) | ALDH1A1CYP3A4HSD17B10KEAP1NFE2L2 | |
| SCHEMBL7431903 | 0.78 | SLC1A3 (0.50) | CA2CA1CA9SCN1ASCN2A | |
| SCHEMBL1195870 | 0.76 | CA2 (0.60) | CA2KDM4ECYP1A2CYP2C19HSD17B10 | |
| SCHEMBL27207228 | 0.76 | CA1 (0.44) | CA2CA1CA9SCN1ASCN2A | |
| SCHEMBL8648359 | 0.76 | CA1 (0.55) | CA2CA1CA9SCN1ASCN2A | |
| SCHEMBL6572028 | 0.75 | SLC1A3 (0.57) | CA2CA1CA9ALDH1A1F2 | |
| SCHEMBL3245449 | 0.74 | CA1 (0.57) | CA2CA1CA9F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605146-B2 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | claimed |
| US-20020077456-A1 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2002-06-20 | — | — | US | claimed |
| EP-1199312-A2 | Process for producing an amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | claimed |
| US-7605146-B2 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20020077456-A1 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2002-06-20 | — | — | US | disclosed |
| EP-1199312-A2 | Process for producing an amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077456-A1 | Process for producing an amide compound | NAAA, ACMSD, CPS1 | CA2 1391/4885CA1 286/4885CA9 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.